EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

MYC: there is more to it than cancer

Mariano F Zacarías-Fluck, Laura Soucek, Jonathan R Whitfield

Frontiers in Cell and Developmental Biology · 06.03.2024 · 12

DOI: 10.3389/fcell.2024.1342872 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 06.03.2024. Verfasst von Mariano F Zacarías-Fluck und 2 weiteren Autor:innen. Beteiligte Einrichtung: Models of Cancer Therapies Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 202 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MYC is a pleiotropic transcription factor involved in multiple cellular processes. While its mechanism of action and targets are not completely elucidated, it has a fundamental role in cellular proliferation, differentiation, metabolism, ribogenesis, and bone and vascular development. Over 4 decades of research and some 10,000 publications linking it to tumorigenesis (by searching PubMed for “MYC oncogene”) have led to MYC becoming a most-wanted target for the treatment of cancer, where many of MYC’s physiological functions become co-opted for tumour initiation and maintenance. In this context, an abundance of reviews describes strategies for potentially targeting MYC in the oncology field. However, its multiple roles in different aspects of cellular biology suggest that it may also play a role in many additional diseases, and other publications are indeed linking MYC to pathologies beyond cancer. Here, we review these physiological functions and the current literature linking MYC to non-oncological diseases. The intense efforts towards developing MYC inhibitors as a cancer therapy will potentially have huge implications for the treatment of other diseases. In addition, with a complementary approach, we discuss some diseases and conditions where MYC appears to play a protective role and hence its increased expression or activation could be therapeutic.

Schlagwörter

Stichwörter der Autor:innen

MYCnon-oncological diseasestargetingtherapytranscription factor

Autor:innen und Institutionen

  • Models of Cancer Therapies Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
  • Peptomyc S.L., Barcelona, Spain.

Zitieren

APA

Zacarías-Fluck, M. F., Soucek, L., & Whitfield, J. R. (2024). MYC: there is more to it than cancer. Frontiers in Cell and Developmental Biology, 12. https://doi.org/10.3389/fcell.2024.1342872

Vancouver

Zacarías-Fluck MF, Soucek L, Whitfield JR. MYC: there is more to it than cancer. Frontiers in Cell and Developmental Biology. 2024;12. doi:10.3389/fcell.2024.1342872

BibTeX
@article{ZacarasFluck2024,
  author = {Zacarías-Fluck, Mariano F and Soucek, Laura and Whitfield, Jonathan R},
  title = {MYC: there is more to it than cancer},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2024},
  volume = {12},
  doi = {10.3389/fcell.2024.1342872}
}
Kostenlos starten →